{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:43:25Z","timestamp":1790621005078,"version":"4.1.0"},"reference-count":12,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2017,12,13]],"date-time":"2017-12-13T00:00:00Z","timestamp":1513123200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Parenter Enteral Nutr"],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Teduglutide is a glucagon\u2010like peptide 2 (GLP\u20102) analog that has been approved for the treatment of adult short bowel syndrome (SBS)\u2013associated intestinal failure (IF; SBS\u2010IF). Teduglutide increases villus height and crypt depth in the small bowel mucosa, promoting nutrition absorption and enteral independence from parenteral nutrition (PN). We aim to report our single\u2010center experience with teduglutide in adult patients with SBS to provide real\u2010world context to its use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>\n                      We conducted a retrospective analysis on patients managed within our tertiary\u2010level intestinal rehabilitation program to identify patients with SBS\u2010IF treated with teduglutide from 2009\u20132015. The current report includes all patients at our center who had\n                      <jats:italic>any<\/jats:italic>\n                      exposure to teduglutide, including those who received commercial drug after approval by the Food and Drug Administration (FDA) and outside the scope of clinical trials.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 18 patients were treated with teduglutide. Eleven patients (61%) achieved complete enteral independence from PN and\/or intravenous fluids (IV) at a median time of 10\u00a0months (range: 3\u201336 months). PN\/IV volume requirement was reduced in all patients except two. Ten of the 11 patients (91%) who achieved enteral autonomy had colon. All patients off PN\/IV required additional oral vitamins and electrolyte supplementations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our preliminary experience is consistent with prior reports of successful partial or complete weaning from PN\/IV with teduglutide treatment in adult patients with SBS. The presence of colon appears to be favorable in obtaining enteral independence from PN\/IV, regardless of residual small bowel length. Patients on teduglutide may remain at high risk of micronutrient deficiencies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/jpen.1011","type":"journal-article","created":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T03:45:19Z","timestamp":1603165519000},"page":"225-230","source":"Crossref","is-referenced-by-count":45,"title":["Single\u2010Center Experience with the Use of Teduglutide in Adult Patients with Short Bowel Syndrome"],"prefix":"10.1002","volume":"42","author":[{"given":"Kwai","family":"Lam","sequence":"first","affiliation":[{"name":"Mount Sinai Medical Center  New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Mount Sinai Medical Center  New York NY USA"},{"name":"The Concord Medical Group  New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Batisti","sequence":"additional","affiliation":[{"name":"Mount Sinai Medical Center  New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishore R.","family":"Iyer","sequence":"additional","affiliation":[{"name":"Mount Sinai Medical Center  New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,12,13]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2013.03.016"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1177\/0148607113512678"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.061440"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.218271"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.12.029"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1177\/0148607111414431"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1586\/egh.11.82"},{"issue":"2015","key":"e_1_2_7_9_1","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1038\/ctg.2015.69","article-title":"Long\u2010term teduglutide for the treatment of patients with intestinal failure associated with short bowel syndrome","volume":"7","author":"Schwartz LK","year":"2016","journal-title":"Clin Transl Gastroenterol"},{"key":"e_1_2_7_10_1","first-page":"14860711668079","article-title":"Independence from parenteral nutrition and intravenous fluid support during treatment with teduglutide among patients with intestinal failure associated with short bowel syndrome.","volume":"2016","author":"Iyer KR","journal-title":"J Parenter Enter Nutr"},{"issue":"8","key":"e_1_2_7_11_1","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1177\/0148607115594010","article-title":"Clinical management of patients with parenteral nutrition\u2010dependent short bowel syndrome during teduglutide therapy.","volume":"40","author":"Compher C","year":"2015","journal-title":"J Parenter Enter Nutr"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.47.3.370"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.22555"}],"container-title":["Journal of Parenteral and Enteral Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjpen.1011","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/aspenjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jpen.1011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T08:51:08Z","timestamp":1760863868000},"score":1,"resource":{"primary":{"URL":"https:\/\/aspenjournals.onlinelibrary.wiley.com\/doi\/10.1002\/jpen.1011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,13]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["10.1002\/jpen.1011"],"URL":"https:\/\/doi.org\/10.1002\/jpen.1011","archive":["Portico"],"relation":{},"ISSN":["0148-6071","1941-2444"],"issn-type":[{"value":"0148-6071","type":"print"},{"value":"1941-2444","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,13]]}}}